ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR
· Real-Time Price · USD
2.04
0.02 (0.99%)
At close: Aug 15, 2025, 3:59 PM
2.05
0.24%
After-hours: Aug 15, 2025, 04:10 PM EDT
ProQR Therapeutics Cash Flow Statement
Financials in EUR. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -10.08M | -9.3M | -8.11M | -2.71M | -7.7M | -5.34M | -5.42M | -7.98M | -8.86M | -11.39M | -24.38M | -14.67M | -14.45M | -18.24M | -15.07M | -15.75M | -12.62M |
Depreciation & Amortization | 678K | 671K | 688K | 711K | 691K | 709.32K | 642K | 594K | 549K | 748K | 612K | 591K | 570K | 552K | 544K | 602K | 631K |
Stock-Based Compensation | 758K | 568K | 612K | 628K | 736K | 802K | 444K | 765K | 1.09M | -387K | 1.33M | 738K | 1.18M | 1.78M | 1.72M | 1.47M | 1.25M |
Other Working Capital | -6.72M | -543K | 1.12M | -4.61M | -9.22M | 2.3M | -2.01M | -3.62M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Non-Cash Items | -434K | -739K | 34K | -75.39K | 320K | -3.37M | -1.08M | -571K | -354K | -1.04M | 3.54M | -2.34M | -3.72M | 333K | 87K | 1.73M | 319K |
Deferred Income Tax | n/a | n/a | n/a | -200K | 3K | 5K | -83K | 464K | n/a | -96K | 69K | 20K | 7K | 22K | 35K | 53K | 7K |
Change in Working Capital | -6.72M | -543K | 1.12M | -4.61M | -9.28M | 2.3M | -2.01M | -3.62M | 52.29M | -5.67M | 3.46M | 820K | -4.05M | 19.34M | 4.63M | 1.92M | -1.35M |
Operating Cash Flow | -15.8M | -9.35M | -5.66M | -6.26M | -15.13M | -5.32M | -7.51M | -10.35M | 44.73M | -17.83M | -15.36M | -14.84M | -20.47M | 3.79M | -8.06M | -9.98M | -11.76M |
Capital Expenditures | -224K | -133K | -286K | -262.33K | -736.31K | -2.87M | -339K | -294K | -136K | 13K | -246K | -231K | -244K | -225K | -175K | -52K | -32K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | 12.14K | -22.42 | 663.52 | 46.53K | 5.72K | n/a | n/a | n/a | 59.33K | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | 139.89K | -17.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | 17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -2.65M | n/a | -144.56K | n/a | 5.6M | 22.42 | -663.52 | 472.00 | 281.41 | n/a | n/a | n/a | 59K | n/a | n/a | n/a |
Investing Cash Flow | -224K | -2.79M | 16.71M | -267K | -17.73M | 5M | -339K | -294K | -89K | 19K | -246K | -231K | -244K | -166K | -175K | -52K | -32K |
Debt Repayment | -567K | -253K | -454K | -294K | -581K | -1.29M | -432K | -647K | -259K | -359K | -43.75M | -357K | -576K | 26.58M | -63K | 555K | -236K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 67K | 71.68M | 1K | 12K | 162K | 240.33K | 151K | 4K | n/a | 1K | n/a | n/a | 33K | 363K | 402K | 185K | 569K |
Financial Cash Flow | -500K | 71.43M | -453K | -282K | -419K | -1.09M | -281K | -643K | -259K | 13.76M | -43.75M | -357K | -543K | 26.94M | 23.56M | 83.34M | 2.98M |
Net Cash Flow | -16.99M | 60.01M | 10.43M | -6.74M | -33.21M | -1.63M | -8.01M | -10.42M | 44.21M | -5.66M | -55.97M | -11.21M | -19.91M | 31.38M | 16.7M | 71.56M | -7.96M |
Free Cash Flow | -16.02M | -9.48M | -5.94M | -6.52M | -15.96M | -8.36M | -7.85M | -10.64M | 44.59M | -17.82M | -15.61M | -15.07M | -20.71M | 3.56M | -8.23M | -10.03M | -11.79M |